Introduction
The kidney plays an essential role in metabolism and clearance of numerous hydrophilic xenobiotics and endogenous compounds.
1 As a consequence, the kidney is oen exposed to drugs with high concentrations and is more susceptible to damage by drugs, which may ultimately cause acute kidney injury (AKI). 2 In fact, drug-induced AKI is a long-term concern in clinical pharmacology and accounts for 19% to 26% of cases of AKI in clinical practice, 3 which is a major reason for postmarketing withdrawals of medicinal products. 4, 5 At present, serum creatinine (SCr) and blood urea nitrogen (BUN) are conventional nephrotoxicity biomarkers for the evaluation of drug-induced AKI, 6 but they are not available for early diagnosis 7, 8 and usually affected by a variety of other diseases.
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Moreover, a limited number of early biomarkers have been explored during the AKI process. For these reasons, innovative preclinical nephrotoxicity screening methods are required to evaluate early nephrotoxicity for drug development and clinical application.
Reactive oxygen species (ROS), mainly produced in mitochondria, have been revealed as the inevitable by-products in renal drug metabolism, which may lead to cell apoptosis and other acute kidney damage.
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For example, cisplatin, a commonly used chemotherapeutic drug for treatment of numerous human cancers, is known to cause serious nephrotoxicity among certain populations. 12 In general, cisplatin can preferentially accumulate in renal tubular cells and induce mitochondrial dysfunction due to the increase of endogenous ROS level via depletion of GSH and inactivation of antioxidant enzymes, [12] [13] [14] which results in the induction of tubular epithelial cell damage. 15 Hence the superoxide anion radical (O 2 c À ), the precursor of most ROS, 16 can therefore act as an early symptom of nephrotoxicity for detecting and studying drug-induced AKI. Hence, the development of noninvasive detection of O 2 c À in mitochondria would be an efficient way to evaluate and predict drug-induced AKI. Fluorescence imaging techniques, as a noninvasive tool, create enormous possibilities and provide new opportunities for the detection of small-molecules and real-time evaluation of cellular damage in preclinical studies. however, the proposed product 7 (or Naph-OH) shows a single peak at 13.3 min (or 8.5 min). Upon the addition of O 2 c À to the probe solution for 30 min, a peak corresponding to the compound 7 (or Naph-OH) appeared at 13.3 min (or 8.5 min) and the peak of the probe at 22.1 min (or 19.5 min) decreased in the meantime. Therefore, the results are in good agreement with the proposed mechanism (Scheme S2 †). interfering oxidants and nucleophilic reagents in this experiment. As shown in Fig. 2A and B 
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The protective effect of antioxidants against cisplatin-induced oxidative stress would occur in experimental nephrotoxicity, 51, 52 such as L-carnitine (LC), an L-lysine derivative. We observed that human kidney 2 (HK-2) cells only display feeble uorescence when incubated with NIR-O 2 c À for 30 min (Fig. 4a) . In contrast, HK-2 cells gave bright uorescence and dose-dependent enhancement when the cells were preincubated with different concentrations of cisplatin (100-1000 mM) for 12 h and then treated with NIR-O 2 c À for another 30 min (Fig. 4a-e) . A 3.7-fold uorescence enhancement was observed aer incubation with 1000 mM cisplatin (Fig. 4j) . However, the uorescence is signicantly reduced (Fig. 4f-j) in a dosedependent way by the pretreatment with L-carnitine (LC), a known antioxidant that could against cisplatin-induced oxidative stress in experimental nephrotoxicity. 53 Moreover, a similar uorescence change could be observed by using probe Naph-O 2 c À in a two-photon model in HK-2 cells in cisplatininduced nephrotoxicity (Fig. S26 †) . In short, these observations indicate that NIR-O 2 c À and Naph-O 2 c À are promising Moreover, the uorescence signal changes can be detected in kidney tissue-incubated Naph-O 2 c À at a depth of 130 mm in the two-photon mode (Fig. S27 †) . The imaging depth can be detected to be 50 mm deeper than that in the one-photon mode (Fig. S28 †) . The changes of the detectable uorescence signal were also observed in AKI kidney tissues within 110 mm by using probe NIR-O 2 c À (Fig. S29 †) . In summary, these results demon- (Fig. S30 †) . We proposed that this may be due to other side effects of cisplatin, which can lead to liver injury to a less serious extent.
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To further verify the possibility of monitoring cisplatin-induced nephrotoxicity in vivo by using NIR-O 2 c À , intraperitoneal injection of cisplatin in dose-dependent (0, 10 and 20 mg kg À1 ) and time-dependent (12, 24, 48 and 72 h) manners were carried out, and then the probe (100 mL of 100 mM stock solution) was injected through the tail vein of the mice. Aer 45 min, the kidneys were harvested from the mice for uorescence imaging.
As shown in Fig. 6B , the images captured from the cisplatinstimulated mice exhibited remarkable enhancement of signals in the kidney, while no change of uorescence intensity was observed for the control samples that were only treated with the probe. The results indicated that the cisplatin could cause severe acute kidney injury at a 20 mg kg À1 dose and 48 h treatment time (Fig. 6C) . Consequently, it is conceivable that NIR-O 2 c À is appropriate for evaluating cisplatin-induced nephrotoxicity in response to oxidative stress. Finally, probe NIR-O 2 c À was employed to evaluate cisplatininduced nephrotoxicity and L-carnitine (LC) remediation in vivo (Fig. 7A) . The experiment was divided into three groups. One group was injected with PBS (320 mL) in the peritoneal cavity, followed by intravenous injection with NIR-O 2 c À (100 mL, 100 mM) as the negative control group; the second group was intraperitoneally injected with cisplatin (320 mL, 20 mg kg À1 ), followed by intravenous injection with the probe NIR-O 2 c À (100 mL, 100 mM) 48 h later; while the third group was intraperitoneally injected with LC (60 mL, 400 mg kg À1 ) 48 h before cisplatin (320 mL, 20 mg kg À1 ), followed by intravenous injection with the probe NIR-O 2 c À (100 mL, 100 mM). As shown in Fig. 7A , the kidney of the mice pretreated with cisplatin exhibited a distinct uorescence increase (Fig. 7A(e) ) compared to the control group (Fig. 7A(d) ). Excitingly, the uorescence of the LC pretreatment group was dramatically suppressed compared with that of the group without LC, which should be ascribed to the alleviation of the kidney injury caused by the drug LC (Fig. 7A(f) ). It is worth noting that a similar phenomenon can be observed in the liver with a smaller variation degree of uorescence (Fig. S31 †) , which may be a slight liver injury caused by the side effects of drug cisplatin. 54 In addition, the protective effect of LC was also identied by hematoxylin-eosin (H&E) staining. Compared with the cisplatin treated kidney, the proportion of injured kidney tissues is much smaller when pretreated with LC (Fig. 7B) . The results indicated that LC could reduce the injury caused by cisplatin to the kidney, which was consistent with uorescence imaging (Fig. 7A) . To the best of our knowledge, NIR-O 2 c À is the rst NIR uorescent probe for the imaging of O 2 c À in drug induced nephrotoxicity.
Conclusions
In summary, we have constructed a two-photon uorescent probe Naph-O 2 c À and a NIR uorescent probe NIR-O 2 c À with mitochondria-targeting ability by probe-screening strategies, which are used for highly selective monitoring of O 2 c À in vitro and in vivo. The utility of these reaction-based probes for O 2 c À detection has been fully veried in terms of their excellent sensitivity and selectivity to various biological oxidants and nucleophilic reagents. Moreover, the excellent performance in cell and tissue imaging illustrated that probes Naph-O 2 c À and NIR-O 2 c À could be used to monitor endogenous O 2 c À by twophoton or one-photon uorescence confocal microscopy. Furthermore, probe NIR-O 2 c À was further demonstrated to be able to visualize the cisplatin-induced acute kidney injury and LC remediation related to O 2 c À levels in vivo for the rst time.
We anticipate that these probes can serve as promising uorescent tools for facilitate biomedical study on the roles of O 2 c À in various kidney injury diseases.
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